You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2013
|
| DOI | 10.1002/14651858.cd006922.pub3 |
| Pubmed ID | |
| Authors |
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt, Montse Ferrer |
| Abstract |
Epidemiological evidence has suggested a link between beta2-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe. This is an updated systematic review. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 15% |
| Ireland | 2 | 10% |
| Kenya | 1 | 5% |
| Japan | 1 | 5% |
| Chile | 1 | 5% |
| Unknown | 12 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 85% |
| Practitioners (doctors, other healthcare professionals) | 2 | 10% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 3 | 3% |
| Colombia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 103 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 22% |
| Researcher | 13 | 12% |
| Student > Ph. D. Student | 13 | 12% |
| Student > Doctoral Student | 10 | 9% |
| Student > Postgraduate | 9 | 8% |
| Other | 20 | 19% |
| Unknown | 19 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 44% |
| Nursing and Health Professions | 9 | 8% |
| Psychology | 6 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Social Sciences | 3 | 3% |
| Other | 12 | 11% |
| Unknown | 26 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2013.
All research outputs
#2,200,114
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#4,617
of 13,156 outputs
Outputs of similar age
#17,593
of 210,810 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 214 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.